Loberamisal for Acute Ischemic Stroke: The LAIS Randomized Clinical Trial
Listen to this summary
The LAIS trial aimed to evaluate the efficacy and safety of intravenous loberamisal in improving functional outcomes for patients with acute ischemic stroke treated within 48 hours of symptom onset. The results indicated that loberamisal significantly increased the proportion of patients achieving favorable functional outcomes at 90 days compared to placebo, suggesting its potential as a neuroprotective therapy. However, further research is necessary to confirm these findings and assess their applicability to a wider patient population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from JAMA
View all →Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 21, 2026 · JAMA
Vaccines for Cancer: A Translational Science Review
Sep 21, 2026 · JAMA
Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act
Sep 17, 2026 · JAMA
Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement: A Randomized Clinical Trial
Sep 16, 2026 · JAMA
Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials
Sep 16, 2026 · JAMA
Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive Outcomes: The CREST-H Substudy of the CREST-2 Randomized Clinical Trial
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 22, 2026 · Lancet (London, England)
Understanding peripheral arterial disease in the current era
Sep 22, 2026 · Lancet (London, England)
Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
